Christopher Krawtschuk - 01 Mar 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
01 Mar 2024
Net transactions value
$0
Form type
4
Filing time
05 Mar 2024, 17:39:56 UTC
Previous filing
08 Dec 2023
Next filing
19 Nov 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +199,000 $0.000000 199,000 01 Mar 2024 Common Stock 199,000 $1.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option will vest over a four-year period at the rate of 25% on the first anniversary of March 1, 2024, and then in equal monthly installments for the remaining 36 months.